| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/ARD.49.2.109 |
| P8608 | Fatcat ID | release_2by5o3q5qvb2rds22r4lswcuwe |
| P932 | PMC publication ID | 1003989 |
| P698 | PubMed publication ID | 2107799 |
| P5875 | ResearchGate publication ID | 21047832 |
| P50 | author | Ricard Cervera i Segura | Q53547424 |
| Josep Font | Q73474655 | ||
| Miguel Ingelmo | Q73600642 | ||
| A. Urbano-Márquez | Q114416214 | ||
| P2093 | author name string | López-Soto A | |
| Pallarés L | |||
| Bové A | |||
| Casals F | |||
| P2860 | cites work | Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid | Q47696821 |
| Antiphospholipid antibodies in systemic lupus erythematosus: evidence of an association with positive Coombs' and hypocomplementemia | Q68294585 | ||
| Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients | Q68826686 | ||
| Anticardiolipin antibodies in patients with rheumatic diseases | Q69198661 | ||
| [Relation of antiphospholipid antibodies to thrombotic phenomena and clinical activity of systemic lupus erythematosus] | Q70395880 | ||
| Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant | Q70439267 | ||
| Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results | Q93670714 | ||
| Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus | Q28261335 | ||
| Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women | Q28290612 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificity | Q33421366 | ||
| Anticardiolipin antibodies in patients with systemic lupus erythematosus. | Q33446776 | ||
| Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients | Q33447381 | ||
| Pathogenetic potential of antiphospholipid antibodies | Q33447488 | ||
| IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated clinical syndromes | Q33448023 | ||
| Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. | Q33449267 | ||
| Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus | Q33450603 | ||
| Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test | Q33453407 | ||
| Anticardiolipin antibodies: isotype distribution and phospholipid specificity | Q33456927 | ||
| Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus | Q33458388 | ||
| Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants | Q33458492 | ||
| Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant | Q33478061 | ||
| Thrombosis in patients with the lupus anticoagulant | Q33486691 | ||
| Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies | Q33557638 | ||
| Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies | Q33570170 | ||
| Anticardiolipin antibodies--clinical associations | Q36707524 | ||
| The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level | Q39289964 | ||
| Immunologic aspects of recurrent abortion and fetal death | Q39596799 | ||
| The relationship of anti-DNA antibody idiotypes and anti-cardiolipin antibodies to disease activity in systemic lupus erythematosus | Q41365701 | ||
| Thrombotic phenomena and lupus anticoagulant in a series of 112 patients with systemic lupus erythematosus | Q46572482 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| antibody | Q79460 | ||
| P304 | page(s) | 109-113 | |
| P577 | publication date | 1990-02-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients | |
| P478 | volume | 49 |
| Q38008403 | 'Overlap' syndromes |
| Q33490042 | 'Primary', 'secondary' and other variants of the antiphospholipid syndrome |
| Q33487561 | A family study of anticardiolipin antibodies and associated clinical conditions |
| Q24675466 | Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment |
| Q35552703 | Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy |
| Q33499417 | Antibodies to thromboplastin in systemic lupus erythematosus: isotype distribution and clinical significance in a series of 92 patients |
| Q71691168 | Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study |
| Q68026186 | Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus |
| Q71984959 | Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis |
| Q67886354 | Antiendothelial Cell Antibodies in Patients with the Antiphospholipid Syndrome |
| Q33893371 | Antiphospholipid (Hughes) syndrome in systemic lupus erythematosus |
| Q39647780 | Antiphospholipid antibodies in thromboangiitis obliterans |
| Q42778868 | Antiphospholipid antibodies: which and when? |
| Q53349053 | Antiphospholipid syndrome in SLE. |
| Q33341941 | Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients |
| Q33567403 | Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients |
| Q61914430 | Chapter 8 Systemic Manifestations of the Antiphospholipid Syndrome |
| Q40519206 | Clinicopathologic correlations of the antiphospholipid syndrome |
| Q57650031 | Distribution of two common idiotypes of anticardiolipin antibodies in sera of patients with primary antiphospholipid syndrome, systemic lupus erythematosus and monoclonal gammopathies |
| Q47685798 | Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes |
| Q45739101 | Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus |
| Q67911740 | High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome |
| Q56907703 | Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE) |
| Q36081533 | Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy |
| Q45785432 | Lack of relationship between human immunodeficiency virus infection and systemic lupus erythematosus |
| Q33358817 | Longitudinal survey of anticardiolipin antibodies in systemic lupus erythematosus. Relationships with clinical manifestations and disease activity in an Italian series |
| Q37551634 | Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution |
| Q35172091 | Pregnancy outcome in systemic lupus erythematosus: good news for the new millennium |
| Q68153286 | Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus |
| Q42993885 | Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome |
| Q33363443 | Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus |
| Q33692770 | Review on Effectiveness of Primary Prophylaxis in aPLs with and without Risk Factors for Thrombosis: Efficacy and Safety |
| Q35548094 | Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults |
| Q33355187 | Systemic lupus erythematosus in men: clinical and immunological characteristics |
| Q33563933 | Systemic lupus erythematosus in the elderly: clinical and immunological characteristics |
| Q51035970 | Systemic lupus erythematosus: clinical manifestations and immunological parameters in 194 patients. Subgroup classification of SLE. |
| Q33371184 | The ‘Primary’ Antiphospholipid Syndrome: Antiphospholipid Antibody Pattern and Clinical Features of a Series of 23 Patients |
| Q43910570 | True anti-anionic phospholipid immunoglobulin M antibodies can exert lupus anticoagulant activity |
| Q39443120 | Vasculitis in systemic lupus erythematosus |
| Q77541312 | [The lung in antiphospholipid syndrome] |
Search more.